Catalyst Funds Management’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-11,900
Closed -$16.5K 692
2025
Q1
$16.5K Buy
+11,900
New +$16.5K ﹤0.01% 442